
Sign up to save your podcasts
Or


$WIT has released its Q4 FY'24 earnings, showing slight sequential growth of 0.1% in IT services revenue in reported currency. Notable highlights include a 17.4% increase in large deal bookings year-over-year, reaching $4.6 billion. However, Q4 margins improved only modestly, indicating ongoing challenges in the economic landscape. The introduction of their AI platform offers future growth potential. Looking ahead, there's cautious guidance for Q1 2025 with flat to slight growth anticipated. More insights at http://valueverge.com/WIT.
$MTB is releasing its Q4 2024 earnings. Key stats: EPS of $3.77 (beat by $0.03) and revenue at $2.39B, reflecting a 3.7% Y/Y growth. Highlights include stable net interest income and improved asset quality with significant reductions in criticized loans.
$USB has released its Q4 2024 earnings report. The company reported an EPS of $1.01, slightly missing estimates, alongside revenues of $6.98B, which saw a 3.68% increase Y/Y but also fell short of expectations. Key performance highlights include a CET1 capital ratio of 10.6% and a return on tangible common equity of 18.3%.
$MS has released its Q4 2024 earnings, showing a solid EPS of $2.22, beating expectations by $0.54, and revenues of $16.22B, up 25.8% Y/Y, exceeding estimates. Strong financial health is highlighted by a 71.1% efficiency ratio and a 20.2% return on tangible capital.
$BAC reported its Q4 2024 earnings with EPS of $0.82, beating estimates by $0.05, and revenue of $25.35B, reflecting a 15.43% year-over-year growth despite challenges in the market. Key highlights include an increase in net interest income and loan growth across all segments, particularly commercial loans (+5% YoY). The CET1 ratio improved to 11.9%, indicating strong financial health. Future risks include interest rate volatility and market uncertainties. For more insights, check http://valueverge.com/BAC.
$UNH has announced its Q4 2024 earnings, with EPS at $6.81, beating estimates by $0.07, while revenue of $100.81B fell short by $927.68M (6.76% Y/Y). Highlights include a medical care ratio of 86.5%, which indicates challenges, particularly from unexpected expenses and slower growth in certain sectors. Future growth hinges on their strong Medicare Advantage retention and expansion in Optum Health. Risks also lie with pricing regulations and previous reimbursement trends. Check the details at http://valueverge.com/UNH.
$INFY has released its Q4 and FY24 earnings report, showing a constant currency revenue growth of 1.4%. Key aspects include a flat YoY Q4 revenue and a decline of 2.2% QoQ. Operating margins slipped to 20.1%. Risks involve a major contract renegotiation impacting revenue. Looking forward, FY25 revenue growth is forecasted at 1% to 3%, with margins expected between 20% and 22%. The focus remains on AI, cloud capabilities, and strategic acquisitions. Check details at http://valueverge.com/INFY.
$BK has released its Q4 2024 earnings report with impressive results. Key highlights include an EPS of $1.72 (up 33% YoY), revenue surpassing $4.85B (up 12.43% YoY), and a robust return on tangible common equity of 23%. Risks include uncertainty in macroeconomic conditions and geopolitical tensions.
From the publisher's feed